AR and prostate carcinoma: In fact, fatty acid synthase (FASN) inhibitor antagonizes the growth of castration-resistant prostate cancer cells and results in reduced protein expression and transcriptional activity of both full-length AR and AR-V7; importantly, in vivo, FASN inhibitor reduced the growth of AR-V7-driven prostate cancer xenografts [242].